Cracking the Code: How Cancer Evades Antibody-Drug Conjugates and New Strategies to Overcome Resistance
Antibody-drug conjugates (ADCs) have emerged as revolutionary agents in oncology, representing a precision-guided approach that targets cancer cells with high ...
